Multi-Omics Approaches for Building Software as Medical Devices: Software as Medical Devices for Cancer Applications - presented by Dr Ashok Palaniappan | Q&A Session with Dr. Vaithilingam Natarajan: SaMD in Clinical Practice - presented by Mr Natarajan Vaithilingam FRCSEd; MS(UK); FEBS

Multi-Omics Approaches for Building Software as Medical Devices

Dr Ashok PalaniappanMr Natarajan Vaithilingam FRCSEd; MS(UK); FEBS

Call for papers

Special Collection: Software as Medical Devices for Cancer Applications

This Special Collection calls for contributions that advance software as medical device applications for the screening, early detection, differential diagnosis, prognosis and improved clinical management of cancers.

With the increasing growth in data in medicine, the development of computational methods and workflows to effectively harness this resource and turn it into actionable information is in great need. Artificial Intelligence (including deep learning, machine learning, and data analytics software) is set to play a transformative role in the future of medicine, and this Special Collection on “Software as Medical Devices for Cancer Applications” will be a timely contribution to the state-of-the-art with respect to the single most burdensome group of diseases, viz. Cancers.

Image credit: Diabetesmagazijn.nl (Unsplash) .

Image credit: Markus Spiske (Unsplash) .

References
  • 1.
    A. S. Balraj et al. (2024) PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma. Technology in Cancer Research & Treatment
  • 2.
    M. Rahimi and F. Asadi (2023) Oncological Applications of Quantum Machine Learning. Technology in Cancer Research & Treatment

Associated Technology in Cancer Research & Treatment article

S. Muthamilselvan et al. (2023) Microfluidics for Profiling miRNA Biomarker Panels in AI-Assisted Cancer Diagnosis and Prognosis. Technology in Cancer Research & Treatment
Article of record
1. Software as Medical Devices for Cancer Applications
Dr Ashok Palaniappan
Ashok Palaniappan
SASTRA University

With the explosion of data in medicine, the development of computational methods and workflows to effectively harness this resource and turn it into actionable information is the need of the hour. Artificial Intelligence (including deep learning, machine learning, and data analytics) is set to play a revolutionary role in the future of medicine, and embracing the AI revolution is vital to transform health outcomes. At the same time, attention needs to be paid to ensure that the deployment of AI devices does not worsen healthcare disparities. Democratic precision medicine constitutes the promise of the AI revolution. We have initiated a Special Collection on “Software as Medical Devices for Cancer Applications” that aims to collate cutting-edge research articles and state-of-the-art reviews that push the boundaries to realize the promise of AI for human health. Specifically, this Special Collection calls for contributions that advance software as medical device applications for the screening, early detection, differential diagnosis, prognosis and improved clinical management of cancers. The seminar will provide a technical background for the Special Collection and also examine the ethical dimensions that need to be evaluated prior to the deployment of customized AI physician assistants.

References
  • 1.
    S. Muthamilselvan et al. (2023) Microfluidics for Profiling miRNA Biomarker Panels in AI-Assisted Cancer Diagnosis and Prognosis. Technology in Cancer Research & Treatment
  • 2.
    J. Y. Kim et al. (2024) Development and preliminary testing of Health Equity Across the AI Lifecycle (HEAAL): A framework for healthcare delivery organizations to mitigate the risk of AI solutions worsening health inequities. PLOS Digital Health
  • 3.
    S. M. McKinney et al. (2020) International evaluation of an AI system for breast cancer screening. Nature
Grants
    Science and Engineering Research BoardEMR/2017/000470
2. Q&A Session with Dr. Vaithilingam Natarajan: SaMD in Clinical Practice
Mr Natarajan Vaithilingam FRCSEd; MS(UK); FEBS
Natarajan Vaithilingam
United Lincolnshire Hospitals NHS Trust

Dr Vaithi will be providing a practitioner's perspective on the use of AI in the clinic. The session will cover the state-of-the-art, and the promise of software as medical devices to aid medical/clinical decision making. He will discuss the pitfalls to watch out for in the adoption of such systems, and share ideas on the role and increasing adoption of AI in medicine in the future. This session will be in the form of Q&A, and Dr Vaithi will be available afterward to answer questions from the audience.

Technology in Cancer Research & Treatment logo
Technology in Cancer Research & Treatment Seminars
Technology in Cancer Research & Treatment
Cite as
A. Palaniappan and N. Vaithilingam (2024, November 20), Multi-Omics Approaches for Building Software as Medical Devices
Share
Details
Listed seminar This seminar is open to all
Recorded Available to all
Video length 56:17
Q&A Now closed
Disclaimer The views expressed in this seminar are those of the speakers and not necessarily those of the journal